News

03/10/08 - ZARS Pharma Announces Worldwide License Agreement with Galderma Pharma

02/27/08 - ZARS Pharma Announces Marketing Authorization of Rapydan in Europe

08/24/07 - Nicholas L. Teti, Jr. joins ZARS Pharma's Board of Directors

07/25/07 - ZARS Initiates Phase 3 Clinical Trial of ThermoProfen

04/19/07 - ZARS Announces First European Marketing Approval and License Agreement

07/06/06 - ZARS Pharma Announces FDA Approval of a Topical Local Anesthetic Peel (Lidocaine and Tetracaine) 7%/7%

06/19/06 - Synera, A New Topical Anesthetic Patch Developed by ZARS Pharma, Is Launched